Repros Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (33)

Latest Posts

About This Stock More About This Stock
Notable Insider Buys: Continental Resources, Fox, Groupon And More
Article By: Benzinga
Saturday, June 27, 2020 7:24 PM EDT
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit. So insider buying can be an encouraging signal for potential investors.
In this article: CLR, ED, CATM, RPRX, GRPN, WSBC, EPZM, FOX, VST
Royalty Pharma Jumps Over 50% In Largest IPO Of 2020
Article By: The Fly
Sunday, June 21, 2020 2:36 PM EDT
Shares of Royalty Pharma jumped over 50% above their initial public offering price of $28 on Tuesday, June 16, in the biggest IPO to date in 2020.
In this article: RPRX
Repros Announces Pricing Of $3.0 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, May 18, 2017 3:12 PM EDT
Repros Therapeutics Inc., announced today that it has entered into an underwriting agreement to sell in a public offering 2,744,125 shares of the Company’s common stock.
In this article: RPRX
Premarket Biotech Digest – CBMG Inks New Deal, IPCI Sued, SYRS Gets FDA Nod
Article By: KKD Healthcare Analytics
Tuesday, April 11, 2017 9:34 AM EDT
Geron Corporation stock picked up on the news that the company has agreed to a settlement related to a consolidated class-action securities lawsuit. The company stock jumped over 19 percent in its previous trading session.
FDA Keeping A Partial "Hold" On Repros Therapeutics’ Proellex
Article By: Lorimer Wilson
Monday, April 10, 2017 7:59 PM EDT
The FDA plans to maintain a partial clinical hold on Repros Therapeutics' Proellex so regulators can take extra time in consulting with agency experts on the liver effects spotted in the clinic.
In this article: RPRX

Latest Tweets for $RPRX

No tweets yet!